Skip to content

    REGENXBIO (RGNX) stock price & financials

    View RGNX earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+9.5% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $24.20M
    $21.21M
    $89.01M
    $21.36M
    $29.73M
    +22.9%
    $30.34M
    +43.0%
    $6.39M
    -92.8%
    $108.02M
    +405.7%
    Strengthening
    Operating Profit
    -$62.08M
    -$51.37M
    $12.13M
    -$63.28M
    -$52.41M
    +15.6%
    -$57.64M
    -12.2%
    -$83.36M
    -787.4%
    $29.26M
    Weakening
    Net Profit
    -$59.60M
    -$51.19M
    $6.08M
    -$70.87M
    -$61.94M
    -3.9%
    -$67.15M
    -31.2%
    -$90.05M
    -1580.4%
    $22.71M
    Weakening
    EPS
    $-1.17
    $0.12
    $-1.38
    $-1.20
    -2.6%
    $-1.72
    -1533.3%
    $0.43
    Weakening
    Other Income
    $2.48M
    $182.0K
    -$6.04M
    -$7.59M
    -$9.53M
    -484.1%
    -$9.51M
    -5326.9%
    -$6.69M
    -10.7%
    -$6.55M
    +13.7%
    Weakening
    Interest
    $820.0K
    $9.42M
    $8.57M
    $10.99M
    $13.17M
    +1506.0%
    $12.28M
    +30.4%
    $8.71M
    +1.6%
    $7.79M
    -29.1%
    Stable
    Depreciation
    Profit before Tax
    MarginsOPM
    -256.6%
    -242.1%
    13.6%
    -296.3%
    -176.3%
    +31.3%
    -190.0%
    +21.5%
    -1304.0%
    -9673.9%
    27.1%
    Weakening
    Tax
    ReturnsROIC
    4.7%
    4.1%
    -0.5%
    5.6%
    4.9%
    +3.9%
    5.3%
    +31.2%
    7.1%
    -1.8%
    -132.0%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$75.56M$69.51M$338.43M$345.21M$96.95M$34.52M$57.53M$34.47M$36.49M
    Short-Term Investments$244.20M$226.70M$137.31M$112.23M$267.69M$240.74M$177.16M$195.60M$69.03M
    Total Current Assets$337.91M$345.03M$531.20M$518.83M$415.98M$334.97M$278.00M$281.28M$236.16M
    Net PP&E$28.70M$39.05M$120.28M$192.45M$206.80M$192.59M$171.31M$152.01M$142.32M
    Goodwill
    Intangibles
    Total Assets$543.81M$497.91M$708.16M$1.11B$833.27M$573.97M$465.99M$453.03M$386.62M
    LiabilitiesTotal Current Liabilities$22.18M$33.68M$81.45M$130.47M$130.43M$130.27M$103.19M$118.09M$82.62M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$8.87M$70.15M$84.93M$88.80M$82.22M$74.13M$65.22M$61.60M
    Total Liabilities$34.97M$47.71M$330.41M$349.61M$317.07M$262.23M$206.34M$350.30M$314.85M
    EquityCommon Stock & APIC$4.0K$4.0K$4.0K$4.0K$4.0K$4.0K$5.0K$5.0K$5.0K
    Retained Earnings-$83.02M-$177.82M-$289.07M-$161.23M-$441.55M-$705.05M-$932.15M-$1.13B-$1.19B
    Total Equity$508.85M$450.20M$377.75M$764.30M$516.20M$311.74M$259.65M$102.73M$71.77M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$104.65M-$107.70M-$54.06M$218.88M-$207.49M-$218.41M-$173.13M-$123.96M-$246.67M
    Cash from Investing-$279.36M$93.56M$122.76M-$406.64M-$11.93M$190.94M$103.45M-$15.87M$216.34M
    Cash from Financing$204.44M$8.38M$200.21M$195.25M-$28.84M-$34.97M$92.68M$116.77M-$12.73M
    SummaryCapital Expenditure-$13.28M-$11.72M-$26.87M-$84.17M-$30.72M-$9.96M-$2.44M-$2.41M-$2.99M
    Free Cash Flow$91.37M-$119.42M-$80.93M$134.70M-$238.21M-$228.37M-$175.56M-$126.38M-$249.67M
    FCF Margin41.8%-339.0%-52.4%28.6%-211.3%-253.1%-210.7%-74.1%-143.1%

    Ratios